Winvest Venture Capital
Overview
Winvest Venture Capital is a South Korean venture capital firm founded in 2000 that specializes in early-stage investments in innovative companies across sectors including biotechnology, healthcare, artificial intelligence, and ICT.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Bertis | Feb 2024 | Private Equity | Co-investor |
| GENECAST | Jun 2024 | IPO | Co-investor |
| Qureator | Jun 2022 | Series A | Co-investor |
| HayanMind Inc. | Dec 2021 | Pre-A Bridge | Co-investor |
| Celloram Inc. | Oct 2020 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Winvest Venture Capital based?
Winvest Venture Capital is headquartered in Seoul, South Korea.
When was Winvest Venture Capital founded?
Winvest Venture Capital was founded in 2000.
How many portfolio companies does Winvest Venture Capital have?
Winvest Venture Capital has 7 portfolio companies in Caplight's dataset.
What are some companies in Winvest Venture Capital's portfolio?
Portfolio companies visible on Caplight include Bertis, GENECAST, Qureator, HayanMind Inc., Celloram Inc..
What was Winvest Venture Capital's most recent investment shown here?
Winvest Venture Capital's most recent investment in this portfolio sample was in GENECAST in 2024.
What sectors does Winvest Venture Capital focus on?
Winvest Venture Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Crypto & Web3, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, FinTech, Frontier & Industrial Tech.
What company stages does Winvest Venture Capital focus on?
Winvest Venture Capital typically invests at the Early stage.